This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
government on Thursday unveiled an $800 million package to bolster the life sciences, highlighting officials’ efforts to grow the industry even as biopharma companies have raised alarms about policies they say are deterring them from investing further in the country. LONDON — The U.K.
PharmaceuticalManufacturing & Packaging Congress (PHARMAP 2022) covers the current state of the pharmaceuticalmanufacturing and packaging industry. The Congress gathers pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies.
According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), more than 600 essential medicines are at risk if a proposed restriction on the use of fluorinated substances, per- and polyfluoroalkyl substances (PFAS) across pharmaceuticalmanufacturing in the EEA, is implemented.
PharmaceuticalManufacturing & Packaging Congress (PHARMAP 2021) will be held on the 28th – 29th of June, 2021 at the BGS online platform. PharmaceuticalManufacturing & Packaging Congress provides the networking platform for the decision-makers from the pharmaceutical industry.
Blow-fill-seal (BFS) technology has long been a cornerstone of pharmaceuticalmanufacturing, relied on for packaging sterile liquid medications, including but not limited to ophthalmic and respiratory drug products.
PharmaceuticalManufacturing & Packaging Congress (PHARMAP 2022) is held on June, 20-21, 2022 in Berlin, Germany. PharmaceuticalManufacturing & Packaging Congress provides a networking platform for decision-makers from the pharmaceutical industry to share cases and brand-new solutions in one place.
The event brought together over 330 professionals from across the industry’s value chain PharmaceuticalManufacturing and Packaging Congress (PHARMAP 2024) was held in Amsterdam, Netherlands on April 22-23, 2024. Among the attendees, contract manufacturing organisations, service providers and experts were present.
Leaders of the whole pharma value chain meet at PharmaceuticalManufacturing and Packaging Congress (PHARMAP) to find new connections and discuss trends of the industry.
Bringing together over 225+ exhibitors and showcasing 12000+ products and solutions, the expo will represent diverse industries, including pharmaceuticalmanufacturing, biotechnology, medical devices and diagnostics, cosmeceuticals, nutraceuticals, packaging solutions, and healthcare IT.
The first day of the Congress started with the executive opening panel, where speakers from LabWare, Optel Group, 3V Tech, GSK, PharmaLedger Association, Bushu Pharmaceuticals, PHARMAZAC had a discussion about new models for pharma manufacturing and packaging.
The market for pharmaceuticalpackaging will grow by 8.24 per cent worldwide and the market for pharmaceuticalpackaging machines by 7.5 Steriline will showcase a Robotic Vial Filling Machine (RVFM5) that merges these qualities for the primary packaging of injectable drugs. per cent per year until 2028 1.
Curious about sustainability in pharmaceuticalmanufacturing and the supply chain? EPR Podcast 22 – Pharmaceuticalpackaging – Manu Kittanakere, Gilead The post Joint investment to accelerate UK sustainable biomanufacturing appeared first on European Pharmaceutical Review.
Packaging plays a vital role in maintaining the quality, safety, user-friendliness and marketability of drugs and other pharmaceutical products. Finding the best commercial packaging suppliers in contract marketing. Pharmaceuticalpackaging formats and materials. Pharmaceuticalpackaging formats and materials.
Novo Nordisk has announced plans to invest over 42 billion Danish kroner (nearly £5 billion) starting in 2023, to expand its manufacturing facilities in Kalundborg, Denmark. According to the pharma company , the financing will add to global capacity: from manufacturing of active pharmaceutical ingredients (API) through to packaging.
Warning letters issued by FDA can be an important source of data to study and analyse violations that occur in pharmaceuticalmanufacturing. Such studies can also help companies prepare for their upcoming inspections by enabling them to identify and rectify any issues.
Indeed, a key aspect of EU GMP Annex 1 is the requirement for pharmaceuticalmanufacturers to develop a comprehensive Contamination Control Strategy (CCS) that documents their approach to assuring the sterile drug product’s high quality and, therefore, enhancing patient safety.
43: Identification and Classification of Nonconformities in Moulded and Tubular Glass Containers for PharmaceuticalManufacturing. Specifically, the document covers the development process of glass containers for pharmaceutical products, glass container sampling as well as definition of lots.
Consequently, pharmaceuticalmanufacturers risk their reputation if impersonating products fail to deliver the expected quality or health impact. These may be mislabelled or produced in fake packaging and, most dangerously, there is no regulation around their manufacture. But what exactly does this look like? .
Enhancing talent in pharmaceuticalmanufacturing “Talent and skills are fundamental to successful innovation and industry growth. This newly announced grant is part of the £650 million ‘Life Sci for Growth’ funding package launched in May 2023.
Contract research, development and manufacturing organisation (CRDMO) WuXi STA has broken ground on its new 190-acre pharmaceuticalmanufacturing campus in Middletown, Delaware, US. The biopharmaceutical industry is part of Delaware’s DNA,” stated Delaware Governor John Carney.
Particularly the printed packaging materials where product information is presented. Printed packaging materials typically include product names, active ingredients, concentration, batch numbers, expiry dates, registration numbers, barcodes, etc. Commonly used packaging materials are cartons, inserts, leaflets, printed foil, etc.
Venkatesh, who is responsible for sterile injectable manufacturing and operations within Dr Reddy’s global organisation, also emphasises the role of data analytics, artificial intelligence, and low-cost automation in sterile manufacturing. The third issue in sterile manufacturing is the impact of human beings.
However, with cleanrooms-on-demand representing a feasible and accessible opportunity for those across pharmaceuticalmanufacturing, what are the key challenges in adoption and how can we expect the industry to overcome them to reap the rewards on offer? But with a single dedicated cleanroom environment costing around $2.5
Nexus Pharmaceuticals President and CEO Usman Ahmed said: “We are thrilled to receive the EIR for our Pleasant Prairie facility. This is a major milestone for our company and reflects our commitments to reshoring sterile pharmaceuticalmanufacturing to the US.
Sanofi has signed definitive agreements with Adragos Pharmaceutical, a German contract development and manufacturing organisation (CDMO), for the sale of its pharmaceuticalmanufacturing site in Kawagoe, Japan. The French pharmaceutical company will also enter into a long-term supply agreement with the CDMO.
Revolutionising pharma the adaptive way Pharmaceuticalmanufacturing is undergoing a transformative development, driven by innovative technologies that enable right-first time (RFT) production and adaptive scaling to meet changing demands. Why is adaptive manufacturing necessary?
Pharma Tech Industries, a pharmaceuticalmanufacturing and packaging solutions contractor for wellness products and medical devices, has announced the appointment of their new chief executive officer Darrin T Schellin.
Recent European manufacturing investments Earlier this month, Novo Nordisk announced that it was planning another manufacturing facility expansion, this time at its site in Kalundborg, Denmark. In September, the Novo Nordisk Foundation announced a multi-million financial commitment to another Denmark-based manufacturing facility.
Spanning pharma machinery, packaging, analytical instruments, laboratory technologies, ingredients, and beyond, it offers a comprehensive platform for stakeholders to engage in transformative dialogues and foster strategic partnerships.
It provides an unparalleled platform for stakeholders to participate in extensive dialogues covering pharma machinery, packaging, analytical instruments, laboratory technologies, equipment, ancillaries, ingredients, and beyond. billion (Rs 2.1 lakh crores) in the 2022–2023 fiscal year.
Whereas proper disposal of unused medications, as well as initiatives to reduce packaging waste, chemical waste, and improve recycling programmes, will aid in pro-actively addressing this challenge. This may involve the use of eco-friendly raw materials, green manufacturing processes, and eco-friendly packaging.
Key focus areas in sustainable manufacturing practices From drug discovery and manufacturing to packaging and patient engagement, sustainability should be embedded in every facet of pharma operations. To support MSME pharma companies in meeting these new standards, the government could implement several targeted incentives.
On October 6, 2024, the Federation of Pharma Entrepreneurs (FOPE) and PharmaState Academy conducted Session 6 of the PULSE (Pharma Upgradation & Learning Series for Excellence) initiative, focusing on HVAC Systems and Qualification in pharmaceuticalmanufacturing. The session began with a keynote address by Thiru M.
He mentioned the necessity of having license number, and manufacturer address on certificates of analysis. He also discussed the importance of having retention samples for raw materials and packaging materials and the role of quality control in investigating deviations and ensuring the stability of raw materials.
Fette Compacting Machinery India, Ace Technologies & Packaging Systems, DPB Antibiotics, Lee Pharma, Omniscient Health, hcare, Venkata Narayana Active Ingredients, Unilab Chemicals and Pharmaceuticals, and many others.
In frames of PHARMAP 2023 speakers are going to talk about the sustainable future of the pharma packaging model and present topics regarding recycle-able vs biodegradable solutions in pharma packaging and packaging solutions for security and brand protection.
The company focuses on utilising packaging to minimise end-of-life waste and employs distribution methods that further reduce environmental impact. As Lonza demonstrates, sustainable practices are not just environmental imperatives but essential components of modern pharmaceuticalmanufacturing.
The Food and Drug Administration (FDA) has successfully inspected Nexus Pharmaceuticals’ pharmaceuticalmanufacturing facility located in Pleasant Prairie, Wisconsin, US. The inspection will allow the company to commence commercial operations at the three-storey, 84,000ft² manufacturing facility.
Also, the proliferation of antimicrobial resistance (AMR), where overuse of antibiotics leads to resistant bacteria, making infections harder to treat Additionally, pharmaceuticalmanufacturing consumes substantial amounts of solvents, which are typically highly toxic chemicals, as well as heavy metals.
This R&D is not just for newer healing combinations, but also innovation across the product lifecycle (from formulation to disposal) for drugs that are less resource-intensive, increasing recyclability in packaging, and other environmental benefits like biodegradable formulations to reduce waste.
Pharmaceutical wholesalers act as intermediaries between pharmaceuticalmanufacturers and retailers and facilitate the delivery of the right medicines in a timely, efficient, and secure manner. The post Leading pharmaceutical wholesalers appeared first on Pharmaceutical Technology.
Sometimes, pharmaceuticalmanufacturers employ surface profilometry to assess the roughness of stainless-steel equipment. In other areas, such as secondary packaging or material storage areas, the product isn’t directly exposed to the environment, so there is a lower risk of contamination. if used on pre-cleaned surfaces.
211.130 Packaging and labeling operations quotes, – There shall be written procedures designed to ensure that correct labels, labeling, and packaging materials are used for drug products; such written procedures shall be followed. Different products should not be packaged in proximity unless physical segregation exists.
Name Email Phone Number Company Department State City 1 / 15 How does analytics support adherence to regulatory guidelines in the Indian pharmaceuticalmanufacturing sector? 2 / 15 In the Indian pharmaceutical industry, what does analytics-driven supply chain management primarily focus on?
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content